Oncologic Timely Palliative Care And Remote Monitoring With Electronic Assessments And Telehealth (ON-TARGET)

NCT07674797 — Not applicable, Not yet recruiting, 300 participants, M.D. Anderson Cancer Center

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

Registry	NCT07674797
Status	Not yet recruiting
Phase	Not applicable
Study type	Interventional; randomized, single group, masking: none, supportive care
Enrollment	300 (Estimated)
Sponsor	M.D. Anderson Cancer Center (Other); collaborators: National Institutes of Health (NIH)
Conditions	Oncologic, Palliative Care, Remote Monitoring, Electronic Assessments, Telehealth
Interventions	Questionnaire and Physical Exam (Other)
Dates	start 2026-11-22 (estimated), primary completion 2032-06-30 (estimated), completion 2034-06-30 (estimated), first posted 2026-06-30, last updated 2026-06-30
Locations	1 site in United States

-Summary

To examine how we can provide supportive care for patients with advanced cancer better tailored to their needs

Expand all sections · Collapse all

+Detailed description

Primary Objectives Objective 1: To compare the impact of timely SPC referral and enhanced usual care (i.e., selective referral) on the proportion of participants with an outpatient SPC consultation at (a) 12 weeks (primary outcome) and (b) 24 weeks post-initial screening.

+Arms and interventions

Arm	Type	Interventions
Dose Dense Timely SPC	Experimental	Other: Questionnaire and Physical Exam
Enhanced UC	Experimental	Other: Questionnaire and Physical Exam
Stadard Timely SPC	Experimental	Other: Questionnaire and Physical Exam

Questionnaire and Physical Exam (Other): Patient will complete questionnaires and physical exams

+Outcome measures

Primary outcomes

Self Report Questionnaire [Through study completion; an average of 1 year]

+Eligibility

Sex: All, ages: 18 Years to any

Eligibility Criteria

* Age ≥ 18
* Outpatients who are within 12 weeks of diagnosis of metastatic solid tumors and seen by one of the participating medical oncologists
* Eastern Cooperative Oncology Group Performance Status 0.2
* Able to speak English or Spanish

Exclusion Criteria:

. Cognitive impairment in the opinion of the oncologist necessitating need for a surrogate decision making.

• Previously seen by SPC team at UT MD Anderson

+Locations (1)

Facility	City	Country	Status
MD Anderson Cancer Center	Houston, Texas	United States

+Investigators

David Hui, MD, Principal investigator, M.D. Anderson Cancer Center

My Notes

Public

To Read Reading Read